Intellectual Property
Minneapolis/St. Paul
Challenges When Dealing with Patent Matters
Unlicensed Source Codes
Tools for Auditing a Patent Portfolio
Litigation Density
Naming Problems with BioSimilars
Becoming a Patent Lawyer
Common Law Trademark Rights
Interpretational Differences Between Prosecution and Litigation
Impact of Post-Grant Proceedings
Claim Abstraction Theory
Open Source Initiative
Cost of Registering a Trademark
Patent Strategy Considerations
What is a Patent?
Consequences of Disclosing Confidential Information
Picking a Trademark
Requirements to Receive a Patent
Post-Grant Proceedings and Patent Enforcement
Preventing "Genericide"
Ideal Patent Strategy
Consequences of a Poorly Drafted Patent
Categories of Marks
Biologics vs Small Molecules
Repeating Competitor Audits
Inter Partes Review
Portfolio Dashboard - Inventor Information
Reasons to Consider Joint Ventures
Joint Venture Ground Rules
Freedom to Operate (FTO) Process
Merely Descriptive Refusal
BioSimilar Patenting Litigation Involving Large Amounts of Money
Factors That Cause a Patent to Decline in Value
Assessing Executive Experience
Secondary Meaning of a Trademark
Forward Citation Landscape
Non-Disclosure Agreement
Raising Good Prosecution Visibility
Backward Citations
Moderate Risk Joint Ventures
Litigation and BioSimilar Patenting
Is A United States Registered Trademark Effective in Other Countries?
Attorneys and Patent Profile Analytics
Get Your Assignments Straight - Contribution of Owners
Biologics Price Competition and Innovation Act
Wasting Money on Low-Value Patents
"TM" Symbol
Hiring Patent Council
NDAs and Customers
Determining Likelihood of Confusion
Effective Stay Strategy
Domain Registration Considerations
Trade Name Protection and Trademark Protection
What Do I Give up in Getting My Patent?
Geographic Insight and Patent Profile Analytics
Patent Examination Process
Implementing a Value-Driven Portfolio Process
What Does an Audit Action Sheet Look Like?
What Doesn't a Patent Provide?
Importance of Post-Grant Proceedings
Confidential Information and Business Damage
What is a BioSimilar Product Under US Law?
Using Product Association with IP Assets
Researching Competitors' IP
Mitigating Risks of Past Damages
Value Management and Risk Management
"How Much" - Audit Action Sheet
Picking a Domain Name
Steps to Obtaining a Patent
Scope Concepts and Headnotes
Are BioSimilars Being Approved in the US?
Freedom to Operate
Rewards of the Practice
Licensing Density
The Advantage of Filing First
Different Parts of a Patent Document
PTAB Timing Trial Dynamics
Open Source Software
Why Is Executing an NDA Not Enough?
Helping In-House Council
Importance of Getting a Patent
Marking a Product
First Item on IP To-Do List
What IP Should I Spend Money on First?
Cited Art Landscape
Prior Art in Prosecution vs Prior Art in Litigation
How to Remedy Unwanted Disclosure of Confidential Information
Goal of a Value-Driven Patent Portfolio
Who Determines Substitution Factors?
Low Risk Joint Ventures
Sponsor
Contractual Intellectual Property Rights
Experience
FDA Guidelines for Demonstrating Biosimilarity
Post-Grant Review
A Less Expensive Alternative
Freedom To Operate vs Clearance
Patent Profile Analytics and Managers
Equal Value Patents
Budgeting for Drafting and Prosecution
Auction Audit Sheet - Key Issues to Address
Refused Trademark Recourse
Soft Assets
How Should IP be Considered for Acquisition?
Infringing on Another Patent
Managing OSS
How do Patent Prosecution Services Vary in Value?
Value Management and Cash Flow
How Big Should My First Patent Be?
Copyright
Joint Venture Pitfalls
Prior Art Challenge
How Does the Knowledge Gap Worsen Over Time?
NDAs and Computer Codes
Trade Secrets
Technical Background
What is a BioSimilar?
Post-Grant Options
Trade Dress
Attorneys Not Understanding the Market
Broad Patent Claim
Rebutting a Merely Descriptive Refusal
How Do Patent Portfolio Values Become Concentrated over Time?
What is an Invention?
Patent Ownership and Patent Profile Analytics
How is the Entire Patent Considered Prior Art?
Background
Post-Grant Options and Cost
Prior Art and Rejections
How to Fix the Knowledge Gap
Improving Patent Portfolio Value
Benefits of Audit Action Sheet
Schwegman Lundberg & Woessner & Post Grant Trial Practice
Post-Grant Options and Grounds of Challenge
Common Reasons Trademarks Are Rejected
Joint Ventures and Dispute Resolution
Establishing Confidentiality
Most Common Client Question
5 Year View Point
A Better Way to Allocate Patent Application Budgets
Audit Action Sheet
Risk Profile
Circle "R"
Trademarks and Brand Value
Patent Profile Analytics and Engineers
Value-Driven Patent Portfolio
4 Ways to Prepare your Patent Portfolio for Battle.
Genericide
Engineers Not Understanding Patents
What Should a Company Understand at the End of an IP Audit?
Improperly Marked Product
Patent Owner Rights
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
"Whens" - Audit Action Sheet
Provisional Patent
Specimen
Why Do You Enjoy Being a Lawyer?
What Engineers Can Learn from Patent Profile Analytics
By the Numbers Overview
Should IP be Part of Our Business Plan?
Patent Trial and Appeal Board
Qualifying for a Patent
Patents 101
Evaluation Agreement and Computer Codes
Claim Maps and BioSimilars
OSS Licensing Conditions
Why Perform Risk Profile?
Considerations Before Hiring IP Council
Post-Grant Proceedings
Demonstrating BioSimilarity Under U.S. Law
Types of Inventions That Are Patentable
"Whats" - Audit Action Sheet
How Much Does it Cost to Get a Patent?
Patents and Practicing an Invention
What is a Trademark?
Patent Status Updates
How is Open Source Incorporated into Software?
Segmenting a Portfolio
When is a House like a Patent?
What is Prior Art?
Patent Analytics and Competition
Factors That Make a Patent Valuable
"Claims" of a Patent
Traditional Re-Examination
Discovering Annuity Information
Process for Registering a Trademark in the United States
ITU
Practicing an Invention
Golden Rule of Auditing a Patent Portfolio
Trademark
Types of Intellectual Property Protection
Meet Mark Stignani
High Risk Joint Ventures
Risks of Not Patenting
IP Registration Density
Do Narrow Patents Add Value to a Portfolio?
Approvals of BioSimilars in Europe
Patents and Other Forms of Intellectual Property Protection
Why Are Biologicals so Important?
How Should IP be Considered for Growth?
Inventorship vs Ownership
Cost/Value Curve of a High Level Patent
Post-Grant Options and Estoppel
Cost/Value Curve of Patent a Portfolio
Signing an NDA
Convergence Density
"Who" - Audit Action Sheet
Freedom To Operate
Intellectual Property Protection
How to Navigate BioSimilar Challenges
Limiting Issues Defined in District Court
Date of First Use
Third Party Confidentiality
Patent Citation Ranking
What is a Patent Portfolio?
How Long Does an FTO Take?
Pre-Litigation Challenges
Is There Still a Place for Traditional Re-Examination?
Standard for Getting a Patent
Renewing a Trademark Registration
Patent Profile Analytics and Researchers
Merrifield Synthesis
Unanticipated OSS
Important Attributes to Being a Successful Patent Lawyer
Purposes of a Trademark
First Step in Performing a Patent Portfolio Audit
Why Should Claims Not Be Read on the Prior Art?
Patent Infringement
Am I Required to Search for Prior Art?
Infringement on the Rights of Other Patents
What to Do When First Selecting a Mark
Intent of Patent Laws
Value Management Lifecycle
Impact of US Hatch Waxman Act 1984
Two Main Value Drivers
Inventorship
Tracking Work History
Post-Litigation Challenges
Joint Venture and Financial Agreements
Portfolio Mapping
Hard Assets
"Wheres" - Audit Action Sheet
Advantages of Registering a Trademark
Calculating New Investments
Proper Way to Use a Trademark
Office Action
PTAB Final Argument Trial Dynamics
The Case of the Joint Marketing Agreement Gone Bad
Limited Valuable Patents in Technology Area
Seeking Money from Investors
Patent Portfolio and Budgets/Spending
Provisional vs Non-Provisional Patent
"SM" Symbol
How Does the Knowledge Gap Develop?
Inventors and Patent Analytics
Independent Claim vs Dependent Claim
The Five Components of an Open Source Software Policy
How can OSS Negatively Affect a Company?
Impact of PTAB
How is Open Source Software Enforced?
When to Do a Freedom to Operate
Trademark Filing Considerations
Outside of Law
Downside of Static Budget Allocation for Patents
Attributes of a Good Patent
The Different Types of Marks
How is Schwegman Lundberg & Woessner Different?
Confidential Information
What Should a Company Patent?
Risks of OSS
Forms of Confidential Information
Importance of Freedom To Operate
Trade Names vs Trademarks
Meet David Black
What Makes Schwegman, Lundberg & Woessner Different?
Covered Business Method Review
